Mediq Leadership Team
Arjen Linders
Arjen Linders has been appointed Chief Executive Officer as of March 1st, 2024, ushering in a new era of leadership and vision for our company. Prior to assuming his new role as Mediq’s CEO, Arjen was appointed Chief Commercial Officer in June 2023. Before that, he served as EVP Benelux from August 2019; in September 2022, Arjen was announced to lead the DACH cluster alongside his responsibilities for Benelux. Arjen worked for Philips for 20 years, recently as Senior Vice President & Market Leader of Personal Health and Sleep & Respiratory Care for Philips North America and before that as Cluster Leader Central and Eastern Europe. Starting his career in marketing, he expanded into sales and e-commerce. He moved into general management roles internationally, where he played a key role in organic sales and market share growth, as well as online growth, digital transformation, and direct-to-consumer business model creation. He has worked and lived in the USA, Czech Republic, and the Netherlands. Arjen holds a Masters in Business Administration from the University of Tilburg. Nationality: Dutch
Mark Mattern
Mark joined Mediq in December 2023 as Chief Financial Officer. Prior to joining Mediq, Mark led a successful practice as a management consultant, offering expert commercial advice to a diverse range of SMEs across the globe. Previously, Mark held the position of Global Head of Commercial Finance at AkzoNobel, where he managed an impressive €10+ billion in annual revenue (for all global business units), driving growth, profitability improvement, transformation, and other high-impact initiatives. Before AkzoNobel, Mark's career spanned several key roles at Philips, including CFO for North America, primarily overseeing the business's medical devices, software, and services sectors and other senior finance roles. Prior to his tenure at Philips, Mark worked in public accounting at Arthur Andersen, where he served as a manager. Mark holds a Bachelor of Science in Finance from the W. P. Carey School of Business at Arizona State University. Additionally, he has completed a number of executive education modules at Harvard Business School, focusing on Corporate Value Creation, Portfolio Management, and Strategic CFO responsibilities. Nationality: American and Dutch
Rory Batt
Rory Batt joined Mediq as Chief Digital Officer in August 2022. Rory has an extensive experience in digitalization and digital transformation. Prior to Mediq, Rory spent a decade at the global brewing company AB InBev, most recently as Head of Digital Transformation for the Europe & Middle East business. He has held various leadership roles across multiple markets, leading high growth businesses, delivering large scale business transformation across multiple functions, and massively increasing digital products revenues. Rory holds a master’s degree from Bristol University, where he has won numerous awards, most significantly, Rory has been awarded a best master's dissertation focused on computational modeling of the climate change impact of human emissions & ozone production. Rory is a published scientific author with several publications in Atmospheric Environment. Nationality: British
Alex Jonker
Alex Jonker has been appointed Mediq's Chief Operating Officer in April 2023. He joined Mediq in July 2015 as Executive Vice President Supply Chain. Prior to joining Mediq, Alex was Supply Chain and E-commerce Director and a member of the board of directors at HEMA. Alex spent the majority of his career at HEMA and has over 20 years of experience in retail Supply Chain management on a European scale. Under the leadership of Alex, Mediq has built a state of the art fulfilment centre in Bleiswijk, Netherlands, and merged 7 former smaller warehouses into this new high tech operation to serve customers at the highest level. Alex holds a University degree in Economics and completed a management program at Insead Business School. Nationality: Dutch
Eveline de Wit
Eveline de Wit joined Mediq as Chief HR Officer in June 2018. Before joining Mediq, Eveline worked for Thermo Fisher Scientific as Vice President of Human Resources for their pharma division, Patheon. Besides her HR responsibility, she supported inorganic growth with diligences and integrations in the US and Europe, as the business doubled. Prior to this she worked in HR leadership roles for Univar, GE Capital and Heineken. Eveline holds a Masters degree in business administration from the University of Nijmegen, and a Bachelor degree in hotel management. Nationality: Dutch
Henrik Helmer Hansen
Henrik Helmer Hansen joined Mediq as Chief Transformation Officer in May 2022. Prior to joining Mediq, Henrik served as Vice President Strategy and Commercial Excellence at Atos Medical. In his 7 years tenure at Atos Medical, Henrik led the development of Atos Medical as a direct-to-consumer MedTech company and completed two successful private equity sales processes. Prior to his assignments at Atos Medical, Henrik worked for Maersk and McKinsey & Company. Henrik is an experienced leader with a strong background in strategy, commercial excellence, and transformation. He holds a master’s degree in Economics from the University of Copenhagen and a master’s degree in Finance and Economics from the London School of Economics. Nationality: Danish
Guido Mouws
Guido Mouws stepped into his role as Chief Product Officer and Executive Committee member at Mediq in April 2024, leveraging a distinguished career in procurement and supply chain innovation. Guido joined Mediq as Vice President & Chief Procurement Officer in 2021, driving procurement transformation with a focus on strategic partnerships and supplier innovation. Previously at Philips, he led as Senior Director, enhancing procurement strategies for Global Solutions & Services and the Benelux region. His tenure at Signify and Bosch Security Systems before that laid the groundwork for his expertise in operational excellence and strategic sourcing. Guido’s career showcases a commitment to excellence, innovation, and sustainable healthcare solutions. His educational background includes a Master of Business Administration, underlining his strategic approach to leadership and operational excellence. Nationality: Dutch
Joachim Warnberg
Joachim Warnberg serves as Managing Director of Mediq Nordics, where he is responsible for leading sales and driving profitable growth across Denmark, Sweden, Norway, and Finland. In addition to his executive role, Joachim serves as CEO and Chairman for Mediq Sweden AB and Mediq Norway AS, having joined Mediq in April 2023 as Managing Director of Mediq Sweden. Prior to Mediq, Joachim held the position of Managing Director Nordic at Easyfairs and led commercial operations in the Nordics at ISS Facility Services, where he also served as Group VP Strategy & Transformation. Prior to Mediq, Joachim held the position of Managing Director Nordic at Easyfairs and led commercial operations in the Nordics at ISS Facility Services, where he also served as Group VP Strategy & Transformation. Joachim began his career at Accenture, later leading the firm’s strategy consulting practice in Sweden, and has since held senior executive roles in growth and transformation. Joachim holds a Master’s degree in Business Administration from the Gothenburg School of Economics and ESSCA Angers. Nationality: Swedish
Marcia Luijendijk
Marcia Luijendijk joined Mediq in Sep 2018 where she had several commercial roles in the Management team of Benelux. In 2024 she was appointed Managing Director of Mediq Benelux, leading the organization through a phase of strategic renewal, M&A and performance improvement. With extensive experience in senior commercial and leadership roles across the pharmaceutical and medical devices sectors, she brings a sharp strategic lens and a proven ability to drive sustainable growth. Her earlier role as Commercial Director at Mediq Nederland strengthened her focus on commercial excellence and the evolving needs of the healthcare landscape. Marcia holds a Masters in Human Movement Sciences from the University of Groningen. Nationality: Dutch
Ulrike Linden
Ulrike Linden has served as Managing Director of Mediq Deutschland GmbH and Mediq Diabetes GmbH since July 2025 and is responsible for the strategic and commercial management of the company in the German market. Prior to this, she spent several years as Managing Director of DiaExpert GmbH, a subsidiary of the Mediq Group specializing in diabetes care and digital health solutions. During this time, she played a key role in the further development of the portfolio and the introduction of innovative care concepts. Her professional career began in the marketing and sales sector of the medical technology industry, where she gained extensive experience in brand management, retail management, and product marketing while holding leadership positions. This expertise continues to form the basis for her current focus: the further development of modern, patient-centered care models and digital health services within the Mediq Group. In her current role, she is committed to consistently aligning the company with high-quality care solutions and strong partnerships in the healthcare sector. She holds a master degree of arts in philology. Nationality: German